The novel BPRST classification for hemorrhoidal disease: A cohort study and an algorithm for treatment

Carlos Walter Sobrado1, Carlos de Almeida Obregon1, Lucas Faraco Sobrado1

  • 1Colorectal Surgery Division, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.

Insights

The new BPRST classification for hemorrhoids (HD) is more effective than Goligher's for guiding treatment. This study proposes a new algorithm to manage hemorrhoid disease based on the BPRST system.

Area of Science:

  • Colorectal Surgery
  • Gastroenterology
  • Surgical Innovation

Background:

  • The existing Goligher classification for hemorrhoids (HD), established in 1980, has limitations in addressing critical disease aspects for effective treatment guidance.
  • Current clinical practice requires a more comprehensive classification system to accurately assess hemorrhoid severity and inform therapeutic decisions.

Purpose of the Study:

  • To implement and evaluate the novel BPRST (bleeding, prolapse, reduction, skin tags, thrombosis) classification for hemorrhoids in a clinical setting.
  • To compare the efficacy of the BPRST classification against the traditional Goligher classification in guiding hemorrhoid treatment.
  • To develop and propose a treatment algorithm based on the BPRST classification for managing hemorrhoid disease.

Main Methods:

  • A prospective study was conducted involving patients with hemorrhoids treated between March 2011 and July 2013.
  • Patients were classified using both the Goligher and BPRST systems.
  • Treatment decisions were based on clinical expertise and current guidelines, with comparisons made between classification systems and chosen treatments.

Main Results:

  • 229 patients were included; 28 were lost to follow-up. The BPRST classification showed a stronger correlation with treatment selection compared to the Goligher classification (p < 0.001).
  • Six patients initially classified under Goligher I were re-staged to BPRST III, necessitating conventional hemorrhoidectomy due to thrombosis or significant skin tags.
  • The BPRST system demonstrated fewer outliers, indicating a more precise stratification of hemorrhoid severity relevant to treatment.

Conclusions:

  • The Goligher classification presents significant limitations for practical clinical application in hemorrhoid management.
  • The BPRST classification offers a more detailed assessment, incorporating key factors crucial for selecting optimal treatment strategies for hemorrhoids.
  • The developed treatment algorithm, utilizing the BPRST classification, provides a structured approach to guide the management of complex hemorrhoid cases.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
302
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
489
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
433
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
720
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
513
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
504